Fair enough. I just thought the 2014 trial results would've have been the cause of the poor share price performance, because some scientific types (e.g. on alzforum.org's analysis of pbt2 results) seem to have differing opinions on whether the result meant the trial was a failure or not - hence rendering the trial inconclusive. Could be both management ineptitude and the trial result I guess. In any case, if future clinical trial data is conclusive and positive, I don't see a repeat of past poor performance. IMO.
- Forums
- ASX - By Stock
- ATH
- end of the downside- back in
end of the downside- back in, page-63
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $4.887K | 1.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
48 | 57027004 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 125241201 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
48 | 57027004 | 0.003 |
52 | 82308597 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 125241201 | 25 |
0.005 | 28735782 | 26 |
0.006 | 14397472 | 18 |
0.007 | 47726651 | 22 |
0.008 | 22799732 | 22 |
Last trade - 10.38am 02/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |